|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
The metabotropic glutamate (mGlu) receptors mGlu1 and mGlu5 mediate distinct inositol 1,4,5-trisphosphate (IP3) and Ca2+ signaling patterns, governed in part by differential mechanisms of feedback regulation after activation. Single cell imaging has shown that mGlu1 receptors initiate sustained elevations in IP3 and Ca2+, which are sensitive to agonist concentration. In contrast, mGlu5 receptors are subject to cyclical PKC-dependent uncoupling and consequently mediate coincident IP3 and Ca2+ oscillations that are largely independent of agonist concentration. In this study, we investigated the contribution of Gq/11
protein expression levels in shaping mGlu1/5 receptor-mediated IP3 and Ca2+ signals, using RNA interference (RNAi). RNAi-mediated knockdown of Gq/11
almost abolished the single-cell increase in IP3 caused by mGlu1 and mGlu5 receptor activation. For the mGlu1 receptor, this unmasked baseline Ca2+ oscillations that persisted even at maximal agonist concentrations. mGlu5 receptor-activated Ca2+ oscillations were still observed but were only initiated at high agonist concentrations. Recombinant overexpression of Gq
enhanced IP3 signals after mGlu1 and mGlu5 receptor activation. It is noteworthy that although mGlu5 receptor-mediated IP3 and Ca2+ oscillations in control cells were largely insensitive to agonist concentration, increasing Gq
expression converted these oscillatory signatures to sustained plateau responses in a high proportion of cells. In addition to modulating temporal Ca2+ signals, up- or down-regulation of Gq/11
expression alters the threshold for the concentration of glutamate at which a measurable Ca2+ signal could be detected. These experiments indicate that altering Gq/11
expression levels differentially affects spatiotemporal aspects of IP3 and Ca2+ signaling mediated by the mGlu1 and mGlu5 receptors.
Address correspondence to: Prof. R. A. J. Challiss, Department of Cell Physiology and Pharmacology, University of Leicester, Maurice Shock Medical Sciences Building, University Road, Leicester, LE1 9HN, UK. E-mail: jc36{at}le.ac.uk
This article has been cited by other articles:
![]() |
E. Gutknecht, I. Van der Linden, K. Van Kolen, K. F. C. Verhoeven, G. Vauquelin, and F. M. Dautzenberg Molecular Mechanisms of Corticotropin-Releasing Factor Receptor-Induced Calcium Signaling Mol. Pharmacol., March 1, 2009; 75(3): 648 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, W. Gong, H. Zhou, Y. Wang, F. Xiao, and T. Li siRecords: a database of mammalian RNAi experiments and efficacies Nucleic Acids Res., January 1, 2009; 37(suppl_1): D146 - D149. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gong, Y. Ren, H. Zhou, Y. Wang, S. Kang, and T. Li siDRM: an effective and generally applicable online siRNA design tool Bioinformatics, October 15, 2008; 24(20): 2405 - 2406. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Willets, A. H. Taylor, H. Shaw, J. C. Konje, and R. A. J. Challiss Selective Regulation of H1 Histamine Receptor Signaling by G Protein-Coupled Receptor Kinase 2 in Uterine Smooth Muscle Cells Mol. Endocrinol., August 1, 2008; 22(8): 1893 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taboubi, J. Milanini, E. Delamarre, F. Parat, F. Garrouste, G. Pommier, J. Takasaki, J.-C. Hubaud, H. Kovacic, and M. Lehmann G{alpha}(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration FASEB J, December 1, 2007; 21(14): 4047 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schwendt and J. F. McGinty Regulator of G-Protein Signaling 4 Interacts with Metabotropic Glutamate Receptor Subtype 5 in Rat Striatum: Relevance to Amphetamine Behavioral Sensitization J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 650 - 657. [Abstract] [Full Text] [PDF] |
||||